Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company PharmaNeuroBoost N.V.
DescriptionLow-dose pipamperone and the antipsychotics risperidone and paliperindone
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard IndicationSchizophrenia
Indication DetailsTreat chronic schizophrenia
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today